HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Structural heart disease

TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer

Courtesy of Dr. Carlos Fava. Oncology patients have been excluded from all studies, but many of them have...
solaci -
Learn More
Structural heart disease

Percutaneous Closure Systems Are Safe in TAVR and Aneurysms

Courtesy of Dr. Carlos Fava. Currently, one of our medical challenges is to conduct procedures requiring access with large...
solaci -
Learn More
Structural heart disease

Is Individual Operator Experience Important in TAVR?

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has emerged as a successful alternative for inoperable patients...
solaci -
Learn More
Acute coronary syndromes

Acute Coronary Syndromes After TAVR: Frequent and Not All Undergo Coronary Angiography

Approximately 10% of patients who undergo transcatheter aortic valve replacement (TAVR) are readmitted for an acute coronary...
solaci -
Learn More
Structural heart disease

Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus

The former generation of valves, the balloon expandable (Sapien XT), was associated to less paravalvular leak than...
solaci -
Learn More
Structural heart disease

Is TAVR at Hospitals Without Backup Cardiovascular Surgery Feasible?

Patients undergoing transcatheter aortic valve replacement (TAVR) at hospitals without cardiovascular surgery available are at significantly higher...
solaci -
Learn More
Structural heart disease

Aortic Stenosis and Dialysis: Is TAVR the Strategy of Choice?

Courtesy of Dr. Carlos Fava. TAVR has been shown beneficial in high and moderate risk patients, but there...
solaci -
Learn More
Structural heart disease

CoreValve US Pivotal High Risk Trial: at 5 years, similar results

Courtesy of Dr. Carlos Fava. We are well aware of transcatheter aortic valve replacement’s (TAVR) effect in high-risk...
solaci -
Learn More